Health

The U.S. surgeon general on Friday issued a new advisory on the link between alcohol consumption and increased cancer risk.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months. 

A pickup in the initial public offering market would be a boon to Danaher.

It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling.

The drugmaker's ability to further expand available supply of its obesity and weight loss drugs is crucial.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.